Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Chevalier

Showing results (161-170 of 201) with videos related to

Pageof 21
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 16, 2022
Effect of proximal optimization technique on coronary bifurcation stent failure: Insights from the multicenter randomized PROPOT trialYoshinobu Murasato, Yusuke Watanabe, Masahiro Yamawaki, et al.
The International Journal of Cardiovascular Imaging|October 14, 2010
Temporal changes of coronary artery plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffoldSalvatore Brugaletta, Hector M Garcia-Garcia, Scot Garg, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 21, 2016
Patient-specific image-based computer simulation for theprediction of valve morphology and calcium displacement after TAVI with the Medtronic CoreValve and the Edwards SAPIEN valveCarl Schultz, Ramon Rodriguez-Olivares, Johan Bosmans, et al.
JACC. Cardiovascular Interventions|June 6, 2016
The Impact of Post-Procedural Asymmetry, Expansion, and Eccentricity of Bioresorbable Everolimus-Eluting Scaffold and Metallic Everolimus-Eluting Stent on Clinical Outcomes in the ABSORB II TrialPannipa Suwannasom, Yohei Sotomi, Yuki Ishibashi, et al.
Lancet (London, England)|November 4, 2016
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trialPatrick W Serruys, Bernard Chevalier, Yohei Sotomi, et al.
JACC. Cardiovascular Interventions|December 24, 2011
Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomographyJosep Gomez-Lara, Salvatore Brugaletta, Vasim Farooq, et al.
Circulation|November 25, 2010
Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomesPatrick W Serruys, Yoshinobu Onuma, John A Ormiston, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 27, 2020
Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: the COMPARE-ABSORB randomised clinical trialPieter C Smits, Chun Chin Chang, Bernard Chevalier, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 14, 2014
Bioresorbable vascular scaffold treatment induces the formation of neointimal cap that seals the underlying plaque without compromising the luminal dimensions: a concept based on serial optical coherence tomography dataChristos V Bourantas, Patrick W Serruys, Shimpei Nakatani, et al.
Journal of the American College of Cardiology|October 1, 2011
Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomesPatrick W Serruys, Yoshinobu Onuma, Dariusz Dudek, et al.
Pageof 21

Showing results (161-170 of 201) with videos related to

Sort By:
Pageof 21
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 16, 2022
Effect of proximal optimization technique on coronary bifurcation stent failure: Insights from the multicenter randomized PROPOT trialYoshinobu Murasato, Yusuke Watanabe, Masahiro Yamawaki, et al.
The International Journal of Cardiovascular Imaging|October 14, 2010
Temporal changes of coronary artery plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffoldSalvatore Brugaletta, Hector M Garcia-Garcia, Scot Garg, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 21, 2016
Patient-specific image-based computer simulation for theprediction of valve morphology and calcium displacement after TAVI with the Medtronic CoreValve and the Edwards SAPIEN valveCarl Schultz, Ramon Rodriguez-Olivares, Johan Bosmans, et al.
JACC. Cardiovascular Interventions|June 6, 2016
The Impact of Post-Procedural Asymmetry, Expansion, and Eccentricity of Bioresorbable Everolimus-Eluting Scaffold and Metallic Everolimus-Eluting Stent on Clinical Outcomes in the ABSORB II TrialPannipa Suwannasom, Yohei Sotomi, Yuki Ishibashi, et al.
Lancet (London, England)|November 4, 2016
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trialPatrick W Serruys, Bernard Chevalier, Yohei Sotomi, et al.
JACC. Cardiovascular Interventions|December 24, 2011
Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomographyJosep Gomez-Lara, Salvatore Brugaletta, Vasim Farooq, et al.
Circulation|November 25, 2010
Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomesPatrick W Serruys, Yoshinobu Onuma, John A Ormiston, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 27, 2020
Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: the COMPARE-ABSORB randomised clinical trialPieter C Smits, Chun Chin Chang, Bernard Chevalier, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 14, 2014
Bioresorbable vascular scaffold treatment induces the formation of neointimal cap that seals the underlying plaque without compromising the luminal dimensions: a concept based on serial optical coherence tomography dataChristos V Bourantas, Patrick W Serruys, Shimpei Nakatani, et al.
Journal of the American College of Cardiology|October 1, 2011
Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomesPatrick W Serruys, Yoshinobu Onuma, Dariusz Dudek, et al.
Pageof 21